CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats

Immunobiology

Volumn 216, Issue 9, 2011, Pages 979-987

  Miljković, Djordje ^a   Stanojević, Željka ^a   Momcilović, Miljana ^a   Odoardi, Francesca ^b   Flügel, Alexander ^b   Mostarica Stojković, Marija ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

CXCL12; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neuroinflammation; Spinal cord; T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; STROMAL CELL DERIVED FACTOR 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4 LYMPHOCYTE COUNT; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; IMMUNOPATHOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD4; CHEMOKINE CXCL12; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FREUND'S ADJUVANT; GENE EXPRESSION; HETEROCYCLIC COMPOUNDS; IMMUNIZATION; INTERFERON-GAMMA; INTERLEUKIN-17; MULTIPLE SCLEROSIS; RATS; RATS, INBRED STRAINS; SPECIES SPECIFICITY; SPINAL CORD; T-LYMPHOCYTES; TISSUE EXTRACTS;

EID: 79960837472     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.03.013     Document Type: Article

References (42)

1. Almolda B., Costa M., Montoya M., González B., Castellano B. CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model. J. Neuroimmunol. 2009, 209:65-80.
2. Becher B., Bechmann I., Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. 2006, 84:532-543.
3. Campbell J.J., Hedrick J., Zlotnik A., Siani M.A., Thompson D.A., Butcher E.C. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998, 279:381-384.
4. Cautain B., Damoiseaux J., Bernard I., van Straaten H., van Breda Vriesman P., Boneu B., Druet P., Saoudi A. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 2001, 31:1132-1140.
5. Chung I.Y., Norris J.G., Benveniste E.N. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J. Exp. Med. 1991, 173:801-811.
6. Colamussi M.L., Secchiero P., Gonelli A., Marchisio M., Zauli G., Capitani S. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway. J. Leukoc. Biol. 2001, 69:263-270.
7. Constantinescu C.S., Hilliard B., Ventura E., Wysocka M., Showe L., Lavi E., Fujioka T., Scott P., Trinchieri G., Rostami A. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively. Clin. Immunol. 2001, 98:23-30.
8. Cowden W.B., Cullen F.A., Staykova M.A., Willenborg D.O. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 1998, 88:1-8.
9. Dittel B.N. CD4 T cells: balancing the coming and going of autoimmune-mediated inflammation in the CNS. Brain Behav. Immun. 2008, 22:421-430.
10. DiVietro J.A., Brown D.C., Sklar L.A., Larson R.S., Lawrence M.B. Immobilized stromal cell-derived factor-1alpha triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion. J. Immunol. 2007, 178:3903-3911.
11. Ge S., Pachter J.S. Isolation and culture of microvascular endothelial cells from murine spinal cord. J. Neuroimmunol. 2006, 177:209-214.
12. Gold D.P., Schroder K., Powell H.C., Kelly C.J. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 1997, 27:2863-2869.
13. Gold R., Linington C., Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129:1953-1971.
14. Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 1991, 28:254-260.
15. Kawakami N., Lassmann S., Li Z., Odoardi F., Ritter T., Ziemssen T., Klinkert W.E., Ellwart J.W., Bradl M., Krivacic K., Lassmann H., Ransohoff R.M., Volk H.D., Wekerle H., Linington C., Flügel A. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 2004, 199:185-197.
16. Krishnamoorthy G., Wekerle H. EAE: an immunologist's magic eye. Eur. J. Immunol. 2009, 39:2031-2035.
17. Kroenke M.A., Carlson T.J., Andjelkovic A.V., Segal B.M. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008, 205:1535-1541.
18. Lazarini F., Tham T.N., Casanova P., Arenzana-Seisdedos F., Dubois-Dalcq M. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 2003, 42:139-148.
19. Lukic M.L., Mensah-Brown E., Galadari S., Shahin A. Lack of apoptosis of infiltrating cells as the mechanism of high susceptibility to EAE in DA rats. Dev. Immunol. 2001, 8:193-200.
20. Markovic M., Miljkovic D., Momcilovic M., Popadic D., Miljkovic Z., Savic E., Ramic Z., Mostarica Stojkovic M. Strain difference in susceptibility to experimental autoimmune encephalomyelitis in rats correlates with T(H)1 and T(H)17-inducing cytokine profiles. Mol. Immunol. 2009, 47:141-146.
21. McCandless E.E., Wang Q., Woerner B.M., Harper J.M., Klein R.S. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:8053-8064.
22. Meiron M., Zohar Y., Anunu R., Wildbaum G., Karin N. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J. Exp. Med. 2008, 205:2643-2655.
23. Miljkovic D., Stosic-Grujicic S., Markovic M., Momcilovic M., Ramic Z., Maksimovic-Ivanic D., Mijatovic S., Popadic D., Cvetkovic I., Mostarica-Stojkovic M. Strain difference in susceptibility to experimental autoimmune encephalomyelitis between Albino Oxford and Dark Agouti rats correlates lack of neurological deficits in AO rats could be a consequence of lower generation of NO by with disparity in production of IL-17, but not nitric oxide. J. Neurosci. Res. 2006, 84:379-388.
24. Mostarica-Stojkovic M., Petrovic M., Lukic M.L. Cellular and genetic basis of the relative resistance to the induction of experimental allergic encephalomyelitis (EAE) in albino oxford (AO) rats. Adv. Exp. Med. Biol. 1982, 149:699-702.
25. Mostarica-Stojkovic M., Vukmanovic S., Ramic Z., Lukic M.L. Evidence for target tissue regulation of resistance to the induction of experimental allergic encephalomyelitis in AO rats. J. Neuroimmunol. 1992, 41:97-104.
26. Murphy A.C., Lalor S.J., Lynch M.A., Mills K.H. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2010, 24:641-651.
27. Nanki T., Lipsky P.E. Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J. Immunol. 2000, 164:5010-5014.
28. Palmer M.T., Weaver C.T. Autoimmunity: increasing suspects in the CD4+ T cell lineup. Nat. Immunol. 2010, 11:36-40.
29. Perry V.H., Gordon S. Modulation of CD4 antigen on macrophages and microglia in rat brain. J. Exp. Med. 1987, 166:1138-1143.
30. Prendergast C.T., Anderton S.M. Immune cell entry to central nervous system - current understanding and prospetive therapeutic targets. Endocr. Metab. Immune Disord. Drug Targets 2009, 9:315-327.
31. Sedgwick J., Brostoff S., Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J. Exp. Med. 1987, 165:1058-1075.
32. Sedgwick J.D., Schwender S., Imrich H., Dörries R., Butcher G.W., ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:7438-7442.
33. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 1998, 187:537-546.
34. Staykova M.A., Cowden W., Willenborg D.O. Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation. Immunol. Cell. Biol. 2002, 80:188-197.
35. Stosic-Grujicic S., Ramic Z., Bumbasirevic V., Harhaji L., Mostarica-Stojkovic M. Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant. Clin. Exp. Immunol. 2004, 136:49-55.
36. Stromnes I.M., Cerretti L.M., Liggitt D., Harris R.A., Goverman J.M. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 2008, 14:337-342.
37. Vukmanović S., Mostarica Stojković M., Lukić M.L. Experimental autoimmune encephalomyelitis in " low" and " high" interleukin 2 producer rats. I. Cellular basis of induction. Cell. Immunol. 1989, 121:237-246.
38. Vukmanović S., Mostarica-Stojkovic M., Zalud I., Ramic Z., Lukic M.L. Analysis of T cell subsets after induction of experimental autoimmune encephalomyelitis in susceptible and resistant strains of rats. J. Neuroimmunol. 1990, 27:63-69.
39. Weinberg A.D. Antibodies to OX-40 (CD134) can identify and eliminate autoreactive T cells: implications for human autoimmune disease. Mol. Med. Today 1998, 4:76-83.
40. Wekerle H., Linington C., Lassmann H., Meyermann R. Cellular immune reactivity within the CNS. TINS 1986, 9:271-277.
41. Wheeler R.D., Owens T. The changing face of cytokines in the brain, perspectives from EAE. Curr. Pharm. Des. 2005, 11:1031-1037.
42. Wright N., Hidalgo A., Rodríguez-Frade J.M., Soriano S.F., Mellado M., Parmo-Cabañas M., Briskin M.J., Teixidó J. The chemokine stromal cell-derived factor-1 alpha modulates alpha 4 beta 7 integrin-mediated lymphocyte adhesion to mucosal addressin cell adhesion molecule-1 and fibronectin. J. Immunol. 2002, 168:5268-5277.